![Serum CA19‐9, CA‐125 and CEA as tumor markers for mucinous ovarian tumors - Lertkhachonsuk - 2020 - Journal of Obstetrics and Gynaecology Research - Wiley Online Library Serum CA19‐9, CA‐125 and CEA as tumor markers for mucinous ovarian tumors - Lertkhachonsuk - 2020 - Journal of Obstetrics and Gynaecology Research - Wiley Online Library](https://obgyn.onlinelibrary.wiley.com/cms/asset/4681ab1a-3194-4453-a6c4-16aafd69ec69/jog14427-fig-0001-m.jpg)
Serum CA19‐9, CA‐125 and CEA as tumor markers for mucinous ovarian tumors - Lertkhachonsuk - 2020 - Journal of Obstetrics and Gynaecology Research - Wiley Online Library
Clinical performance of LOCI™-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and AFP in gynecologic
![Frontiers | Factors Influencing the Discordancy Between Intraoperative Frozen Sections and Final Paraffin Pathologies in Ovarian Tumors Frontiers | Factors Influencing the Discordancy Between Intraoperative Frozen Sections and Final Paraffin Pathologies in Ovarian Tumors](https://www.frontiersin.org/files/Articles/694441/fonc-11-694441-HTML-r1/image_m/fonc-11-694441-t001.jpg)
Frontiers | Factors Influencing the Discordancy Between Intraoperative Frozen Sections and Final Paraffin Pathologies in Ovarian Tumors
![ESGO/ISUOG/IOTA/ESGE Consensus Statement on pre-operative diagnosis of ovarian tumors | International Journal of Gynecologic Cancer ESGO/ISUOG/IOTA/ESGE Consensus Statement on pre-operative diagnosis of ovarian tumors | International Journal of Gynecologic Cancer](https://ijgc.bmj.com/content/ijgc/early/2021/06/10/ijgc-2021-002565/F3.large.jpg)
ESGO/ISUOG/IOTA/ESGE Consensus Statement on pre-operative diagnosis of ovarian tumors | International Journal of Gynecologic Cancer
![Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics](https://pubs.rsna.org/cms/10.1148/rg.2021210005/asset/images/medium/rg.2021210005.fig13.gif)
Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics
![Nucleic acids and proteins carried by exosomes of different origins as potential biomarkers for gynecologic cancers: Molecular Therapy - Oncolytics Nucleic acids and proteins carried by exosomes of different origins as potential biomarkers for gynecologic cancers: Molecular Therapy - Oncolytics](https://www.cell.com/cms/attachment/3e6d9fdf-2cd4-463f-bb34-e5c11fcfa603/fx1_lrg.jpg)
Nucleic acids and proteins carried by exosomes of different origins as potential biomarkers for gynecologic cancers: Molecular Therapy - Oncolytics
![Physiologic variations of serum tumor markers in gynecological malignancies during pregnancy: a systematic review | BMC Medicine | Full Text Physiologic variations of serum tumor markers in gynecological malignancies during pregnancy: a systematic review | BMC Medicine | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1741-7015-10-86/MediaObjects/12916_2012_Article_574_Fig1_HTML.jpg)